Recombinant erythropoietin as treatment for the late hyporegenerative anemia of Rh hemolytic disease.
作者信息
Ohls R K, Wirkus P E, Christensen R D
机构信息
Division of Human Development and Aging, University of Utah School of Medicine, Salt Lake City.
出版信息
Pediatrics. 1992 Nov;90(5):678-80.
PMID:1408538
Abstract
Infants with Rh hemolytic disease can develop a "late" anemia characterized by low serum concentrations of erythropoietin but erythroid progenitors that remain highly erythropoietin-responsive. Erythropoietin administration was evaluated in two patients as an alternative to transfusion. Reticulocyte counts increased after 5 days of treatment, and hematocrits increased after 10 days. Neither patient received erythrocyte transfusions following erythropoietin therapy.
摘要
Zotero 插件